RxDoctor Payments Data

Kendra Stark, NP

Family · Fort Wayne, INNPI 1376325126

Payments from drug & device makers

$1,509in general payments, 2019–2025

Across 64 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$349
  • Merck$212
  • Novartis$171
  • Pfizer$119
  • Heartflow, Inc.$98
  • Abiomed$98
  • plus $462 from 12 others

What the payments were for

  • Food & beverage$1,509100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,509 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$33,638
Medicare patients
382
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$50,876
FarxigaDapagliflozin Propanediol14$20,302
JardianceEmpagliflozin11$13,498
Ranolazine ErRanolazine24$2,663
Nitroglycerin63$1,163
Metoprolol Succinate84$624
Ezetimibe35$623
Carvedilol71$598
Isosorbide Mononitrate ErIsosorbide Mononitrate46$484
Losartan Potassium60$457
Atorvastatin Calcium72$457
Diltiazem 24hr Er (Cd)Diltiazem Hcl14$389
Bumetanide13$361
Rosuvastatin Calcium36$328
Amlodipine Besylate42$324

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$119$50,87637 claims
AstraZenecaFarxiga$50$20,30214 claims
Boehringer IngelheimJardiance$59$13,49811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,392 family providers in Indiana.

Other family in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →